Visit
Breaking Updates in Hematological-Oncology
The American Society of Hematology (ASH) 2020 Annual Meeting and Exposition was held on the 5–8 December.
Despite the pandemic, the virtual format showcased outstanding leaps in understanding and treatment in 2020, across malignancies.
Explore our coverage by disease type, including updates from key trials in which new agents are moving forwards.
ASH 2020
Lost of interesting data presented by Jennifer Woyach at #iwCLL2021 📊
🔸 High-risk features predict shorter response to BTKi
🔸 B2M and lymph node size may be helpful
🔸 BTKi resistance driven by specific mutations in many cases
@VJHemOnc @iwCLL #CLLsm #LEUsm #Leukemia
It's time for the relapsed/refractory CLL treatment session at #iwCLL2021!
We've just been watching Andrew Roberts' presentation on resistance to venetoclax 👀💻
Find iwCLL coverage here 👉http://ow.ly/mX2q50GbO4F👈
@VJHemOnc @iwCLL #CLLsm #LEUsm #Leukemia
Looking beyond JAK inhibitors in MPN with @doctorpemm of @MDAndersonNews at the #TexasMPNWorkshop21👨⚕️
🎥 Watch here: http://ow.ly/VqmL50G9Avs
@UTHealthSA #MPNsm #TxMPNW21 #TexasMPNWorkshop21 #MyeloproliferativeNeoplasms #HemOnc #BloodCancerAwarenessMonth #BCAM
ASH 2020
Breaking Updates in Hematological-Oncology
The American Society of Hematology (ASH) 2020 Annual Meeting and Exposition was held on the 5–8 December.
Despite the pandemic, the virtual format showcased outstanding leaps in understanding and treatment in 2020, across malignancies.
Explore our coverage by disease type, including updates from key trials in which new agents are moving forwards.
Lost of interesting data presented by Jennifer Woyach at #iwCLL2021 📊
🔸 High-risk features predict shorter response to BTKi
🔸 B2M and lymph node size may be helpful
🔸 BTKi resistance driven by specific mutations in many cases
@VJHemOnc @iwCLL #CLLsm #LEUsm #Leukemia
It's time for the relapsed/refractory CLL treatment session at #iwCLL2021!
We've just been watching Andrew Roberts' presentation on resistance to venetoclax 👀💻
Find iwCLL coverage here 👉http://ow.ly/mX2q50GbO4F👈
@VJHemOnc @iwCLL #CLLsm #LEUsm #Leukemia
Looking beyond JAK inhibitors in MPN with @doctorpemm of @MDAndersonNews at the #TexasMPNWorkshop21👨⚕️
🎥 Watch here: http://ow.ly/VqmL50G9Avs
@UTHealthSA #MPNsm #TxMPNW21 #TexasMPNWorkshop21 #MyeloproliferativeNeoplasms #HemOnc #BloodCancerAwarenessMonth #BCAM
VJHemOnc is intended for Healthcare Professionals onlyBy choosing to continue, you are confirming that you are a healthcare professional
Sign-up for our Newsletter!
Keep up to date with all the latest news with our monthly newsletter
